Related references
Note: Only part of the references are listed.p12CDK2-AP1 inhibits breast cancer cell proliferation and in vivo tumor growth
Weibing Zhou et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2012)
Cdk2 is Required for Breast Cancer Mediated by the Low-Molecular-Weight Isoform of Cyclin E
Said Akli et al.
CANCER RESEARCH (2011)
Roscovitine, a Selective CDK Inhibitor, Reduces the Basal and Estrogen-Induced Phosphorylation of ER-α in Human ER-Positive Breast Cancer Cells
Jozefa Wesierska-Gadek et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2011)
Pre-clinical evaluation of cyclin-dependent kinase 2 and 1 inhibition in anti-estrogen-sensitive and resistant breast cancer cells
N. Johnson et al.
BRITISH JOURNAL OF CANCER (2010)
Low-Molecular-Weight Cyclin E Can Bypass Letrozole-Induced G1 Arrest in Human Breast Cancer Cells and Tumors
Said Akli et al.
CLINICAL CANCER RESEARCH (2010)
The Development of a Selective Cyclin-Dependent Kinase Inhibitor That Shows Antitumor Activity
Simak Ali et al.
CANCER RESEARCH (2009)
Low molecular weight cyclin E is specific in breast cancer and is associated with mechanisms of tumor progression
Hannah Wingate et al.
CELL CYCLE (2009)
Decreased Expression of p12(DOC-1) Is Associated with More Advanced Tumor Invasion in Human Gastric Cancer Tissues
M. -G. Choi et al.
EUROPEAN SURGICAL RESEARCH (2009)
Apigenin causes G2/M arrest associated with the modulation of p21Cip1 and Cdc2 and activates p53-dependent apoptosis pathway in human breast cancer SK-BR-3 cells
Eun Jeong Choi et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2009)
Cell Cycle Regulator cdk2ap1 Inhibits Prostate Cancer Cell Growth and Modifies Androgen-Responsive Pathway Function
Olga Zolochevska et al.
PROSTATE (2009)
Tumors initiated by constitutive Cdk2 activation exhibit transforming growth factor β resistance and acquire paracrine mitogenic stimulation during progression
Patrick Corsino et al.
CANCER RESEARCH (2007)
Loss of p12CDK2-AP1 expression in human oral squamous cell carcinoma with disrupted transforming growth factor-β-Smad signaling pathway
Hui Peng et al.
NEOPLASIA (2006)
p12CDK2-AP1 mediates DNA damage responses induced by cisplatin
Y Kim et al.
ONCOGENE (2005)
Role of p12CDK2-API in transforming growth factor-β1-mediated growth suppression
MG Hu et al.
CANCER RESEARCH (2004)
Share Paper
